skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i
Do you think the pharma/biotechs sector has risen on (assuming) hopes of vaccine success only for most within the sectors to deflate again when a decisive outcome has played out (does this seem a simplistic view)?
I guess I'm trying to gauge risk factors within these sectors at this time.
Thanks
Mike
Read Answer Asked by mike on September 15, 2020
Q: Hi the great team, do you see correction coming Oct. or Nov. this year as usual or it is correcting in the technology sector already?
Read Answer Asked by victor on September 14, 2020
Q: Howdy - Why didn't Warren buy some Stanley instead of Bank of America? Too small? So for exposure to US financials in the form of a sorta bank isn't MS better positioned than most with no loan default concerns and great exposure to wealth management (high net worth concentration?) Decent divi too. Why no 5i love for MS - is it the symbol of the stock matching what most associate with something horrible? Bothers me. Fondly, Ken
Read Answer Asked by Ken on September 14, 2020
Q: Both GH and ILMN are held in diversified US Portfolio, with weightings of 2.36% and 2,22% respectively. I bought both with initial positions with the intention of adding on other positive future factors. After reading recent Q&A for these two companies, should I own both or just one and if just one, which one?.....thanks....Tom
Read Answer Asked by Tom on September 14, 2020
Q: In a recent missive, David Rosenberg suggests that smallish pharma and biotech companies are the place to look for future growth. As I don't have enough cash on hand to buy a bunch of stocks, can you please suggest a fund or two that would be a good way to play the pharma/biotech sector. Though your focus is mainly Canada, I suspect that the US would be the place to play this sector. Do you agree?

Thanks in advance!
Read Answer Asked by Dave on September 11, 2020
Q: hello 5i:
I hold AVGO, and have done very well with it, but the valuation is beginning to look stretched. I'd like to stay in the same sector, but most tech valuations look high. INTC and LRCX look "reasonable". While not completely similar (subsectors differ), can you give me your opinion of these two companies? I've reviewed other questions eg you like NVDA, but with a PE of 90, as compared to INTC's 9, I can't see this as a contest (yes, I realize there is more to valuation than just looking at PEs). We also own CSU, OTEX, and PANW in this technology, with a small position in PHO. Normally, we're very long time holders eg. bought CSU at $115 (no, not a misprint). Look forward to your comments, as I really dislike stock gains to evaporate, unless they're being held for income.
thanks
Paul L
Read Answer Asked by Paul on September 11, 2020
Q: Your detail quote shows earnings of 21.50, but looking at their earning announcements on tdw it is not even close.
Did they sell an asset that gave them this one time earning.
Your thoughts on this company in the past shows a less then stellar impression yet the year low is 127 and closed yesterday at 328.
How does 5i. see it for a 2 yr or more hold.
Btw - a professional in the field I know thinks their scanner and products are second to none.
Thanks
Read Answer Asked by Leon on September 10, 2020
Q: Hello, I would like to know about the Snowflake ipo and what are your thoughts. The fact that Berkshire and Salesforce are investing big on this makes it look very attractive. Between Snowflake and Palantir what would be your preference? Are they considered to be in the same sector? Thank you!
Read Answer Asked by Shyam on September 10, 2020